In-line 4Q; higher ARPOB drives hospital performance

Company
03 Jun 2024
5 Min read 
  • Apollo Hospitals delivered in-line 4QFY24 performance.
  •  Efforts to improve sales growth momentum and enhance profitability in Healthco.
  •  Reduction in losses in Apollo Healthco drives superior EBITDA growth.
  •  Plans to add 1,500 beds, improve GMV/profitability in Healthco, and add stores.
  •  Maintain BUY on the stock with a TP of INR6750.
  •  Revenue growth in healthcare services and Healthco, with EBITDA margin expansion.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority